Evidence map›Paper›PMID 26257993›Full record

ArticleAdipocyte

Conditional immortalization of primary adipocyte precursor cells.

Christopher Church, Mallory Brown, Matthew S Rodeheffer

Open access · goldAbstract read
In one paragraph

Article in Adipocyte. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Christopher ChurchSection of Comparative Medicine; School of Medicine; Yale University ; New Haven, CT, USA.
Mallory BrownDepartment of Molecular; Cell and Developmental Biology; School of Medicine; Yale University ; New Haven, CT, USA.
Matthew S RodehefferSection of Comparative Medicine; School of Medicine; Yale University ; New Haven, CT, USA ; Department of Molecular; Cell and Developmental Biology; School of Medicine; Yale University ; New Haven, CT, USA ; Yale Stem Cell Center; Yale University ; New Haven, CT, USA.
Yale University · USYale Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of new adipocytes requires the differentiation of adipocyte precursor (AP) cells residing within the adipose tissue stromal-vascular compartment. The objective was to obtain an immortalized primary adipogenic cell line derived from FACS isolated committed APs using the conditional expression of SV40 T antigen. Adipocyte precursors were isolated from white adipose tissue (WAT) using FACS to remove non-adipogenic cell populations from mice expressing a conditionally regulated SV40 T antigen. APs were maintained by continuous culture and induced to undergo adipogenic differentiation. Adipogenesis, determined by Oil Red O staining, was assessed with each passage and compared to wildtype controls. Adipogenic capability was rapidly lost with increased passage number in committed APs with concurrent reduction in cell proliferation and expression of essential late adipogenic genes, including Pparγ and C/ebpα. Thus, FACS purified committed APs have limited capability to undergo expansion and subsequent adipogenic differentiation in vitro even if they are immortalized with the SV40 T antigen.

Indexed as

3-isobutyl-1-methylxanthine; MDIADASCadipocyte precursoradipocyte precursor; IBMXadipogenesisadipose tissue derived adult stem cells; APand IBMX adipogenic differentiation cocktail; SV40 T-Agcell culturedexamethonsoneimmortalizationinsulinpreadipocyteSV40 T large antigen; WATwhite adipose tissue

Identifiers

PMID26257993
PMCPMC4496986
OpenAlexW1881862664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.